[Federal Register Volume 77, Number 20 (Tuesday, January 31, 2012)]
[Notices]
[Pages 4820-4821]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-2002]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


World Trade Center Health Program Scientific/Technical Advisory 
Committee (WTCHP STAC or Advisory Committee), National Institute for 
Occupational Safety and Health (NIOSH)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meetings of the 
aforementioned committee:

    Committee Public Meeting Times and Dates: (All times are Eastern 
Standard Time.)
    12 p.m.-5 p.m., February 15, 2012. 8:30 a.m.-2 p.m., February 
16, 2012.
    Public Comment Times and Dates: (All times are Eastern Standard 
Time.)
    3:45 p.m.-4:45 p.m., on February 15, 2012. 8:45 a.m.-9:45 a.m., 
on February 16, 2012.
    Place: Jacob J. Javits Federal Building, 26 Federal Plaza, New 
York, New York 10278. This meeting is also available by 
teleconference. Please dial 1-800-593-0693 and enter code 37121.
    Status: Open to the public, limited by the capacity of the room, 
which is about 70 persons, and the number of telephone lines. The 
conference line will accommodate up to 300 callers; therefore it is 
suggested that those interested in calling in to listen to the 
committee meeting share a line when possible.
    Please note that the public comment periods end at the times 
indicated above or following the last call for comments, whichever 
is earlier. Members of the public who want to comment must sign up. 
A limited number of time slots are available and will be assigned on 
a first come-first served basis. Each commenter will be provided up 
to five minutes for comment. You can sign up before the meeting by 
mail, facsimile, email, or telephone until all slots are filled. 
When you sign up you must indicate if you will be making your 
comments by telephone or in person. Advance sign up will conclude at 
5 p.m. on February 13, 2012. If time slots are still available, you 
will be able to sign up at the meeting beginning at 11 a.m. on 
February 15 for the public comment period that day, or beginning at 
8 a.m. on February 16, for the public comment period that day. To 
sign up in advance of the meeting, use the contact information that 
follows.
    Mail: NIOSH Docket Office, Robert A. Taft Laboratories, MS-C-34, 
4676 Columbia Parkway, Cincinnati, Ohio 45226.
    Facsimile: (513) 533-8285.
    Email: [email protected].
    Telephone: (513) 533-8611.
    Written comments will also be accepted (see below).
    Security Considerations: Due to mandatory security clearance 
procedures at the Jacob K. Javits Federal Building, in-person 
attendees must present valid government-issued picture 
identification to security personnel upon entering the building and 
go through an airport-type security check. Non-U.S. citizens are 
encouraged to participate in the audio conferencing due to the extra 
clearance involved with in-person attendance. To attend in person, a 
non-U.S. citizen will have to call or send an email to the contact 
person in this Notice before February 1, 2012, and provide passport 
information. You will be notified if clearance to attend the meeting 
in person is received; otherwise, you will not be able to attend the 
meeting in person.
    Background: The Advisory Committee was established by Public Law 
111-347 (The James Zadroga 9/11 Health and Compensation Act of 2010, 
Title XXXIII of the Public Health Service Act), enacted on January 
2, 2011 and codified at 42 U.S.C. 300mm-300mm-61.
    Purpose: The purpose of the Advisory Committee is to review 
scientific and medical evidence and to make recommendations to the 
World Trade Center (WTC) Program Administrator regarding additional 
WTC Health Program eligibility criteria and potential additions to 
the list of covered WTC-related health conditions. Title XXXIII of 
the Public Health Service Act established within the Department of 
Health and Human Services (HHS), the World Trade Center (WTC) Health 
Program, to be administered by the WTC Program Administrator. The 
WTC Health Program provides: (1) Medical monitoring and treatment 
benefits to eligible emergency responders and recovery and cleanup 
workers (including those who are Federal employees) who responded to 
the September 11, 2001, terrorist attacks, and (2) initial health 
evaluation, monitoring, and treatment benefits to residents and 
other building occupants and area workers in New York City, who were 
directly impacted and adversely affected by such attacks 
(``survivors''). Certain specific activities of the WTC Program 
Administrator are reserved to the Secretary, HHS, to delegate at her 
discretion; other WTC Program Administrator duties not explicitly 
reserved to the Secretary, HHS, are assigned to the Director, NIOSH. 
The administration of the Advisory Committee established under 
Section 300mm-1(a) is left to the Director of NIOSH in his role as 
WTC Program Administrator. CDC and NIOSH provide funding, staffing, 
and administrative support services for the Advisory Committee. The 
charter was issued on May 12, 2011, and will expire on May 12, 2013.
    Matters To Be Discussed: The agenda for the Advisory Committee 
meeting includes: discussion of the petition to add cancer to the 
list of covered WTC-related health

[[Page 4821]]

conditions, research needs of the WTC Health Program, and WTC Health 
Program enrollment eligibility criteria for individuals who were 
members of a fire or police department (whether fire or emergency 
personnel, active or retired), worked for a recovery or cleanup 
contractor, or were a volunteer; and performed rescue, recovery, 
demolition, debris cleanup, or other related services at the 
Pentagon site or the Shanksville, Pennsylvania, site of the 
terrorist-related aircraft crashes of September 11, 2001. The agenda 
is subject to change as priorities dictate.
    Submissions to the Docket: Written comments may be submitted. 
The comments should be limited to two pages and submitted to the 
contact person below by February 9, 2012. Efforts will be made to 
provide the two-page written comments received by the deadline below 
to the committee members before the meeting. Comments in excess of 
two pages will be made publicly available at the NIOSH docket 
(http://www.cdc.gov/niosh/docket/archive/docket248.html).
    To provide written comments or to submit comments to the docket, 
send information to the NIOSH Docket Office by one of the following 
means:
    Mail: NIOSH Docket Office, Robert A. Taft Laboratories, MS-C-34, 
4676 Columbia Parkway, Cincinnati, Ohio 45226.
    Facsimile: (513) 533-8285.
    Email: [email protected].
    Telephone: (513) 533-8611.
    Submissions to the docket should reference docket 248.
    Policy on Redaction of Committee Meeting Transcripts (Public 
Comment): Transcripts will be prepared and posted to NIOSH Docket 
248 within 60 days after the meeting. If a person making a comment 
gives his or her name, no attempt will be made to redact that name. 
NIOSH will take reasonable steps to ensure that individuals making 
public comments are aware of the fact that their comments (including 
their name, if provided) will appear in a transcript of the meeting 
posted on a public Web site. Such reasonable steps include: (a) A 
statement read at the start of the meeting stating that transcripts 
will be posted and names of speakers will not be redacted; and (b) A 
printed copy of the statement mentioned in (a) above will be 
displayed on the table where individuals sign up to make public 
comments. If individuals in making a statement reveal personal 
information (e.g., medical information) about themselves, that 
information will not usually be redacted. The CDC Freedom of 
Information Act coordinator will, however, review such revelations 
in accordance with the Freedom of Information Act and if deemed 
appropriate, will redact such information. Disclosures of 
information concerning third party medical information will be 
redacted.
    Contact Person for More Information: Paul J. Middendorf, Ph.D., 
Designated Federal Official, NIOSH, CDC, 4676 Columbia Parkway, 
MailStop R-45, Cincinnati, Ohio 45226, Telephone: 1-(888) 982-4748; 
email: [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: January 25, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2012-2002 Filed 1-30-12; 8:45 am]
BILLING CODE 4163-18-P